UVEAL MELANOMA
Clinical trials for UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted drug tested against rare, aggressive eye cancer
Disease control TerminatedThis study tested an experimental drug called BVD-523 in people with advanced uveal melanoma, a rare cancer that starts in the eye. The goal was to see if the drug could shrink tumors by blocking a specific protein that helps the cancer grow. The trial was small and ended early, …
Matched conditions: UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Radioactive bullet targets advanced cancers in early trial
Disease control TerminatedThis early-stage study tested a new radioactive drug designed to target and destroy advanced solid tumors. It involved 78 patients with various cancers who had run out of standard treatment options. The main goals were to check the treatment's safety, find the right dose, and see…
Matched conditions: UVEAL MELANOMA
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Radiation and eye injections tested to save vision from rare eye cancer
Disease control TerminatedThis study tested a two-part treatment for a rare eye cancer called uveal melanoma. It combined precise radiation therapy with injections of a drug (aflibercept) into the eye. The goal was to see if this approach could control the tumor while better preserving the patient's visio…
Matched conditions: UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC